144 related articles for article (PubMed ID: 19689296)
1. Lymphangiogenesis and anti-tumor immune responses.
Varney ML; Singh S; Backora M; Chen Z; Singh RK
Curr Mol Med; 2009 Aug; 9(6):694-701. PubMed ID: 19689296
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells in inflammatory angiogenesis and lymphangiogenesis.
Bosisio D; Ronca R; Salvi V; Presta M; Sozzani S
Curr Opin Immunol; 2018 Aug; 53():180-186. PubMed ID: 29879585
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.
Gabrilovich DI; Ishida T; Nadaf S; Ohm JE; Carbone DP
Clin Cancer Res; 1999 Oct; 5(10):2963-70. PubMed ID: 10537366
[TBL] [Abstract][Full Text] [Related]
5. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic endothelial cells attenuate inflammation via suppression of dendritic cell maturation.
Christiansen AJ; Dieterich LC; Ohs I; Bachmann SB; Bianchi R; Proulx ST; Hollmén M; Aebischer D; Detmar M
Oncotarget; 2016 Jun; 7(26):39421-39435. PubMed ID: 27270646
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells and their receptors in antitumor immune response.
Srivastava RM; Khar A
Curr Mol Med; 2009 Aug; 9(6):708-24. PubMed ID: 19689298
[TBL] [Abstract][Full Text] [Related]
8. Dendritic Cells and Cancer Immunity.
Gardner A; Ruffell B
Trends Immunol; 2016 Dec; 37(12):855-865. PubMed ID: 27793569
[TBL] [Abstract][Full Text] [Related]
9. Pro-lymphangiogenic properties of IFN-γ-activated human dendritic cells.
Gagliostro V; Seeger P; Garrafa E; Salvi V; Bresciani R; Bosisio D; Sozzani S
Immunol Lett; 2016 May; 173():26-35. PubMed ID: 26987844
[TBL] [Abstract][Full Text] [Related]
10. Physiology and therapeutics of vascular endothelial growth factor in tumor immunosuppression.
Johnson B; Osada T; Clay T; Lyerly H; Morse M
Curr Mol Med; 2009 Aug; 9(6):702-7. PubMed ID: 19689297
[TBL] [Abstract][Full Text] [Related]
11. Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity.
Suryawanshi A; Hussein MS; Prasad PD; Manicassamy S
Front Immunol; 2020; 11():122. PubMed ID: 32132993
[TBL] [Abstract][Full Text] [Related]
12. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis.
Kimura Y; Sumiyoshi M
Phytomedicine; 2013 Feb; 20(3-4):328-36. PubMed ID: 23219337
[TBL] [Abstract][Full Text] [Related]
14. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK
J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441
[TBL] [Abstract][Full Text] [Related]
15. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
[TBL] [Abstract][Full Text] [Related]
16. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics.
Lund AW; Duraes FV; Hirosue S; Raghavan VR; Nembrini C; Thomas SN; Issa A; Hugues S; Swartz MA
Cell Rep; 2012 Mar; 1(3):191-9. PubMed ID: 22832193
[TBL] [Abstract][Full Text] [Related]
17. FcγRIIb inhibits immune complex-induced VEGF-A production and intranodal lymphangiogenesis.
Clatworthy MR; Harford SK; Mathews RJ; Smith KG
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):17971-6. PubMed ID: 25475856
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells pulsed with generated tumor cell lysate from Phyllanthus amarus Schum. & Thonn. induces anti-tumor immune response.
Mohamed SIA; Jantan I; Nafiah MA; Seyed MA; Chan KM
BMC Complement Altern Med; 2018 Aug; 18(1):232. PubMed ID: 30081891
[TBL] [Abstract][Full Text] [Related]
19. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells as vectors for immunotherapy of cancer.
Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK
Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
